Analyst Ratings for Vincerx Pharma (VINC)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/14/2022 | H.C. Wainwright » Updated 3/29/2022 |
Michael G. King, Jr. | New Coverage | Buy (N/A) |
28.00 (25.00) |
7.90 (0.10) |
-98.73% | Details |
| 12/23/2021 | Cantor Fitzgerald | N/A | New Coverage | Overweight (N/A) |
25.00 (N/A) |
10.30 (0.10) |
-99.03% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


